ask="3.18"
ask_size="5600"
average_daily_volume="3602350"
bid="3.00"
bid_size="500"
book_value="-1.75"
change="-0.01"
change_from_200_day_moving_average="-1.64"
change_from_50_day_moving_average="-0.09"
change_from_52_week_high="-5.84"
change_From_52_week_low="0.35"
change_in_percent="-0.31%"
close="3.18"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.37"
ebitda="-120.56M"
eps_estimate_current_year="-1.16"
eps_estimate_next_quarter="-0.10"
eps_estimate_next_year="-0.23"
ex_dividend_date="N/A"
float_shares="113594000"
high="3.23"
high_52_weeks="9.02"
last_trade_date="2/17/2017"
last_trade_price="3.18"
last_trade_size="134208"
last_trade_time="4:00pm"
low="3.15"
low_52_weeks="2.83"
market_capitalization="412.18M"
moving_average_200_day="4.82"
moving_average_50_day="3.27"
name="Merrimack Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="9.00"
open="3.19"
pe_ratio="N/A"
peg_ratio="-0.49"
percent_change_from_200_day_moving_average="-34.07%"
percent_change_from_50_day_moving_average="-2.89%"
percent_change_from_52_week_high="-64.73%"
percent_change_from_52_week_low="+12.37%"
previous_close="3.19"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="3.96"
revenue="104.45M"
shares_outstanding="129615000"
short_ratio="4.68"
stock_exchange="NGM"
symbol="MACK"
volume="1123509"
weeks_range_52="2.83 - 9.02"
